In a significant stride towards advancing cancer treatment, Medivir AB has announced the successful raising of $3,000,000 in funding, a pivotal step for the innovative pharmaceutical company dedicated to addressing pressing unmet medical needs in oncology. Medivir, a trailblazer in the development of targeted cancer therapies, aims to enhance patient outcomes by focusing on drug candidates that cater to indication areas significantly lacking in effective treatments. The raised capital will primarily be utilized to further the clinical development of fostroxacitabine bralpamide (fostrox), an innovative chemotherapy designed to selectively target liver cancer cells while minimizing adverse side effects. This targeted approach not only holds the promise of better efficacy but also a better quality of life for patients undergoing treatment. Collaboration and partnerships form the backbone of Medivir’s business model, and this funding will bolster existing initiatives and facilitate new strategic alliances, accelerating the delivery of vital therapies to the patients who need them most. Medivir, listed under the ticker MVIR on Nasdaq Stockholm's Small Cap list, remains committed to leveraging its scientific expertise and collaborative strategies to navigate the complexities of cancer treatment. As the company embarks on this important journey, the investment serves as a testament to the confidence stakeholders have in Medivir's mission to transform cancer care through innovation.
Medivir Secures $3 Million Investment for Innovative Cancer Drug Development
Get the full Medivir company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Kigen
Kigen is the forerunner in eSIM and iSIM security solutions, built for IoT at scale in the AI era. We simplify cellular IoT adoption for manufacturers by delivering secure-by-design, standards-based solutions that enable global connectivity with confidence. Our technology sets us apart - delivering freedom to choose from 200+ terrestrial and satellite networks, with proven interoperability on leading chipsets and modules. We streamline every step of eSIM and iSIM-enabled product development - from design to volume production and field deployment - reducing risk, time, and costly rework. Mobile IoT Startup of the Year 2024, backed by technology powerhouses Arm, SoftBank Vision Fund 2, and SBI Group. We're the trusted partner for leading global brands in consumer electronics, energy, automotive, logistics, and industrial automation. We enable manufacturers to deploy one globally connected product instead of managing dozens of regional variants. Our solutions provide secure connectivity from factory lines within seconds, transforming how companies approach IoT deployment at scale. Ready to simplify your IoT connectivity challenges? Visit kigen.com or connect with us here to discover how we're building the #FutureofSIM.
$13.5M Unknown
today
SportVot
Every game deserves an audience. Whether it’s a cover drive in Malad, a 3-pointer in Melbourne, or a raid in Ranchi — if it’s not seen, it’s not celebrated. That’s where SportVot comes in. We’re a global sports tech platform built to give every level of sport — from grassroots to elite — the stage it deserves. What we do: Stream matches from community tournaments to international leagues. Power fully remote, hybrid, and automated productions — managed seamlessly through our cloud studio. Help players, teams, and communities turn visibility into recognition and opportunity. The world has noticed — we’re the Winner of SportsPro OTT’s Global Tech Solution of the Year. Because at SportVot, we believe: If you can play it, you should be able to stream it.
$3.5M Unknown
today
Axoft
Developing a seamless bioelectronic interface.
$55.0M Series a
today
Groove Quantum
At Groove quantum, our mission is to enable quantum advantages by realising the most scalable quantum processor, where the scalability is rooted in our semiconductor, germanium qubit platform. With the dedicated and pioneering Groove team, we are sprouting from QuTech in Delft, a world-leading quantum research institute and we are closely connected to the Delft quantum ecosystem.
$18.8M Seed
today
Spiral Hydrogen
Spiral Hydrogen is building next-generation electrolyzers. Based on alkaline electrolyzers, we solve many core problems plaguing current systems. Our electrolyers have no gas bubbles, and achieve efficiencies up to 95%. We use rotation to pump our electrolyte, achiving current densities up to 3 A/cm². In addition, our stack cost is an order magnitude cheaper, due to a simplified stack design and longer lifetime. Our goal is to get the green hydrogen price below fossil hydrogen, unlocking a €250B market for decarbonization and making hydrogen transportation and heating commercially viable. We have validated our technology in lab conditions (TRL 4) and are looking for pilot partners and investors to build our first pilot (TRL 6).
$3.2M Pre-seed
today